Benzinga | Dec 9, 2020 05:43AM EST

United Therapeutics Received FDA Orphan Drug Designation for Treprostinil for Treatment of Idiopathic Pulmonary Fibrosis on December 8, 2020

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=787620